Fusobacterium periodonticum
Selected indexed studies
- Synergism of Fusobacterium periodonticum and N-nitrosamines promote the formation of EMT subtypes in ESCC by modulating Wnt3a palmitoylation. (Gut Microbes, 2024) [PMID:39193618]
- Vertebral osteomyelitis caused by Fusobacterium periodonticum. (J Infect, 2021) [PMID:33248222]
- Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid. (J Transl Med, 2024) [PMID:38689341]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Synergism of Fusobacterium periodonticum and N-nitrosamines promote the formation of EMT subtypes in ESCC by modulating Wnt3a palmitoylation. (2024) pubmed
- Vertebral osteomyelitis caused by Fusobacterium periodonticum. (2021) pubmed
- Fusobacterium periodonticum BCT protein targeting glucose metabolism to promote the epithelial-mesenchymal transition of esophageal cancer cells by lactic acid. (2024) pubmed
- Fretibacterium Species to Fusobacterium periodonticum Ratio as a Potential Biomarker of Periodontitis Based on Salivary Microbiome Profiling. (2024) pubmed
- Lacrimal canaliculitis caused by Fusobacterium periodonticum: A rare clinical encounter. (2025) pubmed
- Fusobacterium periodonticum, a new species from the human oral cavity. (1983) pubmed
- Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum? (2021) pubmed
- Molecular characterization of a 40-kDa outer membrane protein, FomA, of Fusobacterium periodonticum and comparison with Fusobacterium nucleatum. (1995) pubmed
- Development of species-specific polymerase chain reaction primers for detection of Fusobacterium periodonticum. (2010) pubmed
- Development of gastric mucosa-associated microbiota in autoimmune gastritis with neuroendocrine tumors. (2025) pubmed